Rabies Virus Glycoprotein-Mediated Transportation and T Cell Infiltration to Brain Tumor by Magnetoelectric Gold Yarnballs
Source abstract
Abstract
T lymphocyte infiltration with immunotherapy potentially suppresses most devastating brain tumors. However, local immune privilege and tumor heterogeneity usually limit the penetration of immune cells and therapeutic agents into brain tumors, leading to tumor recurrence after treatment. Here, a rabies virus glycoprotein (RVG)-camouflaged gold yarnball (RVG@GY) that can boost the targeting efficiency at a brain tumor via dual hierarchy- and RVG-mediated spinal cord transportation, facilitating the decrease of tumor heterogeneity for T cell infiltration, is developed. Upon magnetoelectric irradiation, the electron current generated on the GYs activates the electrolytic penetration of palbociclib-loaded dendrimer (Den[Pb]) deep into tumors. In addition, the high-density GYs at brain tumors also induces the disruption of cell–cell interactions and T cell infiltration. The integration of the electrolytic effects and T cell infiltration promoted by drug-loaded RVG@GYs deep in the brain tumor elicits sufficient T cell numbers and effectively prolongs the survival rate of mice with orthotopic brain tumors.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Neuroblastoma Research and Treatments · Brain Metastases and Treatment · Polyomavirus and related diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Electrical and Computer Engineering, National Yang Ming Chiao Tung University, Hsinchu 300093, Taiwan
Department of Neurosurgery, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan 33305, Taiwan
Funding
National Tsing Hua University · Ministry of Science and Technology, Taiwan
References (75)
Show source-provided references
1. 10.1038/s41568-019-0224-710.1038/s41568-019-0224-7 ↗
2. 10.1056/NEJMoa04333010.1056/NEJMoa043330 ↗
3. 10.1016/S1470-2045(06)70665-910.1016/S1470-2045(06)70665-9 ↗
4. 10.1007/s11912-020-01007-510.1007/s11912-020-01007-5 ↗
5. 10.1038/s41467-021-23832-310.1038/s41467-021-23832-3 ↗
6. 10.1038/s43018-020-00147-810.1038/s43018-020-00147-8 ↗
7. 10.1016/S0140-6736(11)61346-910.1016/S0140-6736(11)61346-9 ↗
8. 10.3171/foc.2005.19.4.410.3171/foc.2005.19.4.4 ↗
9. 10.1038/nm.340710.1038/nm.3407 ↗
10. 10.1227/00006123-199409000-0000410.1227/00006123-199409000-00004 ↗
11. 10.1158/0008-5472.CAN-07-687810.1158/0008-5472.CAN-07-6878 ↗
12. 10.1007/s11910-008-0036-810.1007/s11910-008-0036-8 ↗
13. 10.1084/jem.2014229010.1084/jem.20142290 ↗
14. 10.1038/s41593-018-0227-910.1038/s41593-018-0227-9 ↗
15. 10.1038/nature1443210.1038/nature14432 ↗
16. 10.1002/anie.20090721010.1002/anie.200907210 ↗
17. 10.1038/s41573-018-0006-z10.1038/s41573-018-0006-z ↗
18. 10.1039/C9CS00271E10.1039/C9CS00271E ↗
19. 10.1021/acsnano.8b0817710.1021/acsnano.8b08177 ↗
20. 10.1021/acsnano.8b0684210.1021/acsnano.8b06842 ↗
21. 10.1016/j.bbamem.2008.10.02210.1016/j.bbamem.2008.10.022 ↗
22. 10.1038/nm.340710.1038/nm.3407 ↗
23. 10.1021/acsnano.6b0385810.1021/acsnano.6b03858 ↗
24. 10.1021/acschemneuro.7b0031210.1021/acschemneuro.7b00312 ↗
25. 10.1021/bm401906p10.1021/bm401906p ↗
26. 10.1021/acs.nanolett.0c0089310.1021/acs.nanolett.0c00893 ↗
27. 10.1021/acs.nanolett.0c0412210.1021/acs.nanolett.0c04122 ↗
28. 10.1039/C9CS00773C10.1039/C9CS00773C ↗
29. 10.1002/anie.20190628810.1002/anie.201906288 ↗
30. 10.1038/s41467-021-23194-w10.1038/s41467-021-23194-w ↗
31. 10.1002/adfm.20200439710.1002/adfm.202004397 ↗
32. 10.1126/science.aaz219310.1126/science.aaz2193 ↗
33. 10.1038/nnano.2016.16010.1038/nnano.2016.160 ↗
34. 10.1038/s41565-018-0356-z10.1038/s41565-018-0356-z ↗
35. 10.1021/acs.nanolett.9b0284110.1021/acs.nanolett.9b02841 ↗
36. 10.1021/acs.chemmater.8b0084010.1021/acs.chemmater.8b00840 ↗
37. 10.1021/acsnano.7b0174410.1021/acsnano.7b01744 ↗
38. 10.1021/acsnano.6b0780610.1021/acsnano.6b07806 ↗
39. Young R. M. · Ann. Transl. Med. · 2015 · 3 · 121
40. 10.1016/j.biopha.2015.12.01410.1016/j.biopha.2015.12.014 ↗
41. 10.1016/j.phrs.2021.10578010.1016/j.phrs.2021.105780 ↗
42. 10.1038/nature2346510.1038/nature23465 ↗
43. 10.1016/j.nano.2012.05.00210.1016/j.nano.2012.05.002 ↗
44. 10.1002/adma.20070130110.1002/adma.200701301 ↗
45. 10.1109/TMAG.2006.87975410.1109/TMAG.2006.879754 ↗
46. 10.1002/adhm.20150067910.1002/adhm.201500679 ↗
47. 10.1038/s41427-020-00244-110.1038/s41427-020-00244-1 ↗
48. 10.1002/adma.20180347410.1002/adma.201803474 ↗
49. 10.1016/j.jconrel.2017.09.00210.1016/j.jconrel.2017.09.002 ↗
50. 10.1186/s11671-018-2728-610.1186/s11671-018-2728-6 ↗
51. 10.3762/bjnano.6.2610.3762/bjnano.6.26 ↗
52. 10.1016/j.nano.2012.05.00210.1016/j.nano.2012.05.002 ↗
53. 10.1016/j.taap.2010.04.01410.1016/j.taap.2010.04.014 ↗
54. 10.1016/j.toxlet.2009.07.01810.1016/j.toxlet.2009.07.018 ↗
55. 10.1016/j.biomaterials.2017.01.00610.1016/j.biomaterials.2017.01.006 ↗
56. 10.1021/nn103530b10.1021/nn103530b ↗
57. 10.1158/1541-7786.MCR-18-020110.1158/1541-7786.MCR-18-0201 ↗
58. 10.1080/2162402X.2021.191624310.1080/2162402X.2021.1916243 ↗
59. 10.1039/C9LC00036D10.1039/C9LC00036D ↗
60. 10.1021/acsnano.6b0232610.1021/acsnano.6b02326 ↗
61. 10.3171/2017.11.FOCUS1762710.3171/2017.11.FOCUS17627 ↗
62. 10.3390/pharmaceutics1004018110.3390/pharmaceutics10040181 ↗
63. 10.1038/nrmicro.2018.1110.1038/nrmicro.2018.11 ↗
64. 10.1080/1355028059090042710.1080/13550280590900427 ↗
65. 10.1146/annurev-virology-100114-05515710.1146/annurev-virology-100114-055157 ↗
66. 10.1016/j.tips.2006.07.00410.1016/j.tips.2006.07.004 ↗
67. 10.1523/JNEUROSCI.17-02-00586.199710.1523/JNEUROSCI.17-02-00586.1997 ↗
68. 10.1002/cne.1013810.1002/cne.10138 ↗
69. 10.1038/nbt.428110.1038/nbt.4281 ↗
70. 10.1073/pnas.95.13.755610.1073/pnas.95.13.7556 ↗
71. 10.1182/blood.V97.1.19210.1182/blood.V97.1.192 ↗
72. 10.1016/j.vaccine.2010.03.00710.1016/j.vaccine.2010.03.007 ↗
73. 10.1038/bjc.2017.36210.1038/bjc.2017.362 ↗
74. 10.1038/s41577-019-0269-610.1038/s41577-019-0269-6 ↗
75. 10.1186/s40169-017-0175-010.1186/s40169-017-0175-0 ↗